Molecular Therapy: Methods & Clinical Development (Sep 2023)

CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy

  • Harry Wilton-Clark,
  • Toshifumi Yokota

Journal volume & issue
Vol. 30
pp. 500 – 501

Abstract

Read online

No abstracts available.